This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pridmore, C. L. Articles by Blaser, S. Search for Related Content PubMed PubMed Citation Articles by Pridmore, C. L. Articles by Blaser, S. Social Bookmarking                         What's this?

Ornithine Transcarbamylase Deficiency in Females: An Often Overlooked Cause of Treatable Encephalopathy

Divisions of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada

Joe T.R. Clarke, MD, PhD, FRCPC, FCCMG

Clinical Genetics, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada

Susan Blaser, MD

Department of Radiology, Hospital for Sick Children, Toronto, Ontario, Canada

Ornithine transcarbamylase deficiency is an X-linked recessive disorder of urea biosynthesis characterized by recurrent, often fatal, hyperammonemic encephalopathy in affected males; carrier females are usually asymptomatic. We report here the clinical and laboratory findings in five symptomatic heterozygous females with ornithine transcarbamylase deficiency. In each case, the onset of symptoms occurred in the 1st year of life, but diagnosis was delayed by up to 15 years. Symptoms included recurrent vomiting with lethargy (five patients), dietary protein intolerance (five), irritability (four), severe acute encephalopathy (three), ataxia (three), and acute hemiparesis (two). All eventually showed evidence of developmental delay or learning difficulties. Two of the three who experienced severe, acute, hyperammonemic encephalopathy suffered serious, permanent neurologic sequelae. Three of the patients showed decreased ornithine transcarbamylase activity in liver obtained by needle biopsy, and the other two had marked orotic aciduria associated with hyperammonemia. Neuroimaging studies demonstrated persistent abnormal lobar attenuation and abnormal signal on computed tomographic scan and magnetic resonance imaging. All patients showed marked symptomatic improvement on treatment with dietary protein restriction supplemented by pharmacologic measures to increase nonprotein nitrogen excretion. Ornithine transcarbamylase deficiency should be considered in the differential diagnosis of acute or chronic encephalopathy in females at any age. (J Child Neurol 1995;10:369-374).

Journal of Child Neurology, Vol. 10, No. 5, 369-374 (1995)
DOI: 10.1177/088307389501000506


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. L. Gropman, N. Sailasuta, K. C. Harris, O. Abulseoud, and B. D. Ross Ornithine Transcarbamylase Deficiency with Persistent Abnormality in Cerebral Glutamate Metabolism in Adults Radiology, September 1, 2009; 252(3): 833 - 841. [Abstract] [Full Text] [PDF]

				M Oechsner, C Steen, H J Sturenburg, and A Kohlschutter Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency J. Neurol. Neurosurg. Psychiatry, May 1, 1998; 64(5): 680 - 682. [Abstract] [Full Text] [PDF]

				C. Keller, S. K. Shapira, and G. D. Clark A Urea Cycle Defect Presenting as Acute Cerebellar Ataxia in a 3-Year-Old Girl J Child Neurol, February 1, 1998; 13(2): 93 - 95. [PDF]